Dificid Patient Assistance Program
Dificid is a prescription antibiotic used to treat diarrhea caused by Clostridioides difficile in adults and children age 6 months and older, an infection of the colon better known as C. diff. It contains fidaxomicin, which targets the bacteria behind the infection while leaving much of the healthy bacteria in your gut intact, an approach that helps lower the odds of the infection coming back.
A C. diff infection can be exhausting and frightening, with relentless diarrhea, cramping, and the worry of it returning just when you think you’ve recovered. Fortunately, a medication like Dificid gives many people a real chance at clearing the infection, but a short course of a specialized antibiotic can carry a steep price.
If affording it is a struggle, whether your coverage falls short or you have none at all, a Patient Assistance Program (PAP) may help you get it when you qualify.
How Prescription Details Affect Dificid Assistance Eligibility

About the Dificid Patient Assistance Program
A program like this exists because the company making the drug sets aside a way to reach patients who need it but can’t take on the cost themselves. Dificid’s is meant for people diagnosed with a C. diff infection whose insurance leaves the price beyond what they can pay.
Beginning the process takes a prescription from the doctor treating your infection, along with paperwork that lays out your household income for the past year.
Once you send those over, we carry the rest. The manufacturer’s required clinical details are requested from your doctor, your income records are shaped to the program’s format, and the whole thing is filed as one application. We watch its progress through review, and if approval comes, your Dificid is sent out so you can complete your treatment. Fitting the requirements doesn’t lock in a yes, because the manufacturer decides each application on its own.
How Dificid Works
A C. diff infection often takes hold after antibiotics disrupt the normal balance of bacteria in your gut, letting C. diff multiply and release toxins that inflame the colon. The result is the persistent diarrhea and cramping the infection is known for.
Fidaxomicin fights the infection with a narrow focus.
Rather than wiping out bacteria broadly, it concentrates its action on C. diff while sparing much of the beneficial bacteria your gut relies on. Staying mostly in the intestine rather than spreading through the body, it goes to work right where the infection lives, and preserving that healthy balance is part of why the infection is less likely to return afterward.
You take Dificid as a tablet twice a day for ten days, with or without food. Finishing the full course is important, even once you feel better, so the infection is fully cleared.
Side Effects and Safety Information
Dificid tends to be well tolerated, in part because so little of it is absorbed into the bloodstream. When side effects do occur, they are usually mild and may include:
- Nausea or vomiting
- Stomach pain
- Gastrointestinal bleeding
- Anemia
- Pediatric patients may experience fever
Serious reactions are uncommon but worth knowing. A severe allergic reaction can happen, with signs like rash, swelling of the face or throat, or difficulty breathing, and any of these calls for emergency care. Because allergic responses have occurred in people sensitive to similar antibiotics, tell your doctor about past reactions before you start.
Dificid is made specifically for C. diff and won’t work against other kinds of infection, so it should only be taken for the infection it was prescribed for. If your symptoms fail to improve or grow worse during treatment, let your doctor know rather than waiting it out.
Step 1 – Submit Application
Provide basic prescription and household information to begin the application process.
Step 2 – Application Review
Information is reviewed and submitted to appropriate Patient Assistance Programs.
Step 3 – Program Decision
Final eligibility decisions are made by each program. Additional steps or renewals may be required.
PHN will contact you within 24 hours to discuss your situation and help identify appropriate next steps for the application process.
How it applies / Eligibility
To qualify, you’ll need to meet all of the following:
- Single patients earning less than $40,000 per year
- Couples making under $60,000 combined yearly
- Households with three or more people bringing in below $100,000 annually
- Active Dificid prescription from your healthcare provider
- Proof of U.S. citizenship or legal residency
- Limited or inadequate prescription drug coverage for Dificid
Income usually carries the most weight, though it’s read alongside your wider situation, and meeting every item here still leaves the final decision with the manufacturer.
Frequently asked questions (FAQ`s)
You’ll get the reason in writing. It’s usually income above the limit, coverage the manufacturer considers enough, or an application that came in incomplete. A denial isn’t the end of it, so a change in your income or the missing document lets you apply again.
Dificid is generally a short, defined course rather than an ongoing medication, so renewal often isn’t a factor. If your treatment does need to continue, you’d provide updated income records and your doctor’s confirmation that it’s still required before any program deadline.
Proof of citizenship or legal residency, a year of household income records, a current Dificid prescription from a licensed provider, and a summary of any drug coverage you have.
Leave the enrollment to us. We confirm you meet the standards, gather your paperwork, coordinate with your care team, and deliver a finished application to the manufacturer.
No generic form of fidaxomicin is available at this time. Patients approved through the program receive brand-name Dificid.
There’s no set timeframe. It depends on how much the manufacturer is handling and how many people are reviewing applications. We keep in touch and share updates as they come.
They can. A manufacturer might revise an income limit or rethink what counts as adequate coverage as its priorities shift. We follow the programs and reach out when a change affects where you stand.